254
Participants
Start Date
November 17, 2020
Primary Completion Date
August 3, 2022
Study Completion Date
September 30, 2022
Lebrikizumab
Given SC
Placebo
Given SC
University of Pittsburgh Medical Center, Pittsburgh
Peak Research LLC, Upper Saint Clair
University of Pennsylvania Hospital, Philadelphia
Medical University of South Carolina, Charleston
Advanced Medical Research, Sandy Springs
Georgia Skin & Cancer Clinic, Savannah
Solutions Through Advanced Research, Jacksonville
Direct Helpers Research Center, Hialeah
The Community Research of South Florida, Hialeah
Wellness Clinical Research, Miami Lakes
Riverchase Dermatology and Cosmetic Surgery, Pembroke Pines
Florida Academic Centers Research and Education, LLC, Coral Gables
International Dermatology Research, Inc., Miami
Sanchez Clinical Research Inc, Miami
New Horizon Research Center, Miami
Miami Dermatology and Laser Research, Miami
Florida Research Center, Inc, Miami
C&R Research Services USA, Kendall
Tampa General Hospital, Tampa
Olympian Clinical Research, Tampa
Clinical Research Center of Alabama- Birmingham, Birmingham
Skin Sciences, PLLC, Louisville
University Hospitals Case Medical Center, Cleveland
Ohio Pediatric Research Association, Dayton
The Indiana Clinical Trials Center, Plainfield
Grekin Skin Institute, Warren
Oakland Dermatology, Auburn Hills
Dundee Dermatology, West Dundee
Sneeze, Wheeze, & Itch Associates LLC, Normal
MediSearch Clinical Trials, Saint Joseph
Kansas City Dermatology, PA, Overland Park
Kansas Medical Clinic, an Elligo Health Research, Inc., Shawnee Mission
Kansas Medical Clinic, Topeka
Advanced Dermatology of the Midlands, Omaha
Tulane Univ School of Med, New Orleans
Burke Pharmaceutical Research, Hot Springs
Arkansas Research Trials, North Little Rock
Unity Clinical Research, Oklahoma City
Central States Research, Tulsa
Vital Prospects Clinical Research Institute, PC, Tulsa
Dermatology Treatment and Research Center, Dallas
Modern Research Associates, Dallas
Arlington Research Center, Inc, Arlington
Center for Clinical Studies, Houston
Suzanne Bruce and Associates, PA, Houston
Bellaire Dermatology Associates, Bellaire
Center for Clinical Studies, Webster
Laredo Dermatology Associates P.A., Laredo
Progressive Clinical Research, San Antonio
Texas Dermatology and Laser Specialists, San Antonio
Austin Institute for Clinical Research, Dripping Springs
IMMUNOe International Research Centers, Centennial
Jordan Valley Dermatology Center, South Jordan
Velocity Clinical Research - Woseth Dermatology, Salt Lake City
Keck School of Medicine University of Southern California, Los Angeles
Dermatology Research Associates, Los Angeles
LA Universal Research Center, INC, Los Angeles
Wallace Medical Group, Inc., Beverly Hills
Ablon Skin Institute and Research Center, Manhattan Beach
Axon Clinical Research, Inglewood
MD Strategies Research Centers MDSRC, San Diego
University Clinical Trials, San Diego
Dermatology Clinical Trials, Newport Beach
Avance Trials, Laguna Niguel
Southern California Dermatology, Inc., Santa Ana
First OC Dermatology, Fountain Valley
Orange County Research Institute, Anaheim
San Luis Dermatology & Laser Clinic, San Luis Obispo
Cura Clinical Research, Palmdale
Synergy Dermatology, San Francisco
Center For Dermatology Clinical Research, Inc., Fremont
Sunwise Clinical Research, Lafayette
Care Access Research, San Jose
Oregon Medical Research Center, Portland
Premier Clinical Research, Spokane
Asthma and Allergy Associates, PC, Colorado Springs
ForCare Clinical Research, Tampa
Tufts Medical Center, Boston
Brigham and Women's Hospital, Boston
Metro Boston Clinical Partners, Brighton
Psoriasis Treatment Center of Central New Jersey, East Windsor
Skin Laser and Surgery Specialists, a Division of Schweiger Dermatology, Hackensack
JUVA Skin & Laser Center, New York
Clinical Partners, LLC, Johnston
AAPRI Clinical Research Institute, Warwick
Eli Lilly and Company
INDUSTRY